跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AN-845
首页
药物
AN-845
AN-845
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Methods for treating cancer using an immunotoxin
US 2007196366 A1
申请人: ZANGEMEISTER-WITTKE UWE
优先权: 2004
US
8 件公开
Binding proteins that bind to EpCAM linked to an effector molecule
US 8263744 B2
申请人: CIZEAU JEANNICK
优先权: 2008
US
2 件公开
Optimized nucleic acid sequences for the expression of VB4-845
US 8318472 B2
申请人: CIZEAU JEANNICK
优先权: 2008
US
2 件公开
METHOD OF DETERMINING ETCH ENDPOINT USING PRINCIPAL COMPONENTS ANALYSIS OF OPTICAL EMISSION SPECTRA
WO 0118845 A1
申请人: ADVANCED MICRO DEVICES INC
优先权: 1999
WO
ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USING SAME FOR INCREASING PLANT YIELD
US 2011197315 A1
申请人: EVOGENE LTD
优先权: 2009
US
Compositions and methods for detection and treatment of hepatocellular carcinoma
CN 105188762 A
申请人: VIVENTIA BIO INC
优先权: 2014
CN
Novel anti-tumor compound thelenota ananas J. saponin in thelenota ananas J.
CN 105884854 A
申请人: NINGBO ZHENHAI LONGSAI HOSPITAL
优先权: 2015
CN
New antitumor compound thelenota ananas saponin in thelenota ananas
CN 108117581 A
申请人: NINGBO ZHENHAI LONGSAN HOSPITAL
优先权: 2016
CN
Improved method of rhodiola rosea extracting process
CN 106581125 A
申请人: TIBET RHODIOLA PHARMACEUTICAL HOLDING COMPANY
优先权: 2016
CN
药物
反馈